BioCorRx Inc. Cash and Restricted Cash
BioCorRx Inc. (BICX) had Cash and Restricted Cash of $21.24 thousand as of 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Cash Flow
us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents · last filed 2026-08-14
- 2026-06-30: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $21.24K.
- 2026-03-31: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $211.91K.
- 2025-12-31: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $139.36K.
- 2025-09-30: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $287.69K.
| Period end | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents |
|---|---|
| 2026-06-30 | $21.24K 10-Q · filed 2026-08-14 |
| 2026-03-31 | $211.91K 10-Q · filed 2026-05-15 |
| 2025-12-31 | $139.36K 10-Q · filed 2026-08-14 |
| 2025-09-30 | $287.69K 10-K · filed 2026-03-31 |
| 2025-06-30 | $111.87K 10-Q · filed 2026-08-14 |
| 2025-03-31 | $24.14K 10-Q · filed 2026-05-15 |
| 2024-12-31 | $88.03K 10-Q · filed 2026-08-14 |
| 2024-09-30 | $90.00 10-Q · filed 2025-11-14 |
| 2024-06-30 | $8.37K 10-Q · filed 2025-08-14 |
| 2024-03-31 | $101.08K 10-Q · filed 2025-05-15 |
| 2023-12-31 | $65.22K 10-K · filed 2026-03-31 |
| 2023-09-30 | $156.41K 10-Q · filed 2024-11-14 |
| 2023-06-30 | $197.30K 10-Q · filed 2024-08-13 |
| 2023-03-31 | $203.69K 10-Q · filed 2024-05-15 |
| 2022-12-31 | $68.61K 10-K · filed 2025-03-31 |
| 2022-09-30 | $63.53K 10-Q · filed 2023-11-14 |
| 2022-06-30 | $111.46K 10-Q · filed 2023-08-14 |
| 2022-03-31 | $213.17K 10-Q · filed 2023-05-15 |
| 2021-12-31 | $85.84K 10-K · filed 2024-04-01 |
| 2021-09-30 | $745.46K 10-Q · filed 2022-11-14 |
| 2020-12-31 | $592.05K 10-K · filed 2023-03-31 |